Open access
57
Views
4
CrossRef citations to date
0
Altmetric
Original Research
Patient satisfaction following transition from the original to the new formulation of subcutaneous interferon beta-1a in relapsing multiple sclerosis: a randomized, two-arm, open-label, Phase IIIb study
William Camu1 MS Clinic, CHU Gui de Chauliac, University of Montpellier I, Montpellier, FranceCorrespondence[email protected]
, Karim Hadjout2 Department of Neurology, Centre Hospitalier, Rodez, France
, Sabine Latour3 Merck Serono S.A. – Geneva, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany
, Dieter Pöhlau4 Multiple Sclerosis Center, Kamillus-Klinik Asbach, Asbach, Germany
& Said Masri5 Praxis Masri, Berlin, Germany
Pages 127-133
|
Published online: 06 May 2010
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.